SPICE organisms: Difference between revisions

From IDWiki
mNo edit summary
m ()
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
= Definition =
== Background ==


* Gram-negative bacteria with inducible or derepressable beta-lactamases, primarily chromosomal AmpC
* Gram-negative bacteria with inducible or derepressable beta-lactamases, primarily [[AmpC β-lactamase]]


= Organisms =
== Organisms ==


* ''Serratia'' spp.
* [[Serratia]]
* ''Providencia''
* [[Providencia]]
* Indole-positive ''Proteae'' (e.g. ''Proteus vulgaris'', but not ''Proteus mirabilis'')
* Indole-positive [[Proteus]] (e.g. [[Proteus vulgaris]], but not [[Proteus mirabilis]])
* ''Citrobacter'' spp.
* [[Citrobacter|'''Citrobacter''']]
** ''C. koseri'' does ''not'' have an AmpC
** [[Citrobacter koseri]] does ''not'' have an AmpC
* [[Enterobacter cloacae|'''Enterobacter cloacae''']], and now also '''[[Klebsiella aerogenes]]''' (previously ''Enterobacter aerogenes'')
* ''Enterobacter cloacae''
* And maybe also:
** [[Hafnia alvei]]
** [[Morganella morganii]]
** [[Cronobacter]]
** [[Edwardsiella]]


== Management ==
Also:


* For [[Enterobacter cloacae]], [[Klebsiella aerogenes]], and [[Citrobacter freundii]], avoid all penicillins and cephalosporins regardless of susceptibility testing
* ''Hafnia alvei''
**[[Carbapenems]] still work, as do [[aminoglycosides]]
* ''Acinetobacter'', though not inducible or AmpC (merely very resistant_
**[[Cefipime]] still works when MIC ≤2 mcg/mL
* ''Morganella morganii''
*For [[Serratia marcescens]], [[Morganella morganii]], and [[Providencia]], treat based on susceptibility testing
* ''Cronobacter''
*Less data for [[Hafnia alvei]], [[Citrobacter youngae]], and [[Yersinia enterocolitica]], but reasonable to treat based on susceptibility testing
* ''Edwardsiella''


== Further Reading ==
= Treatment =

* ''Not'' penicillins or cephalosporins, as resistance will develop within a few days
* Carbapenems still work, as do aminoglycosides

= Further Reading =


* Jones R, Baquero F, Privitera G, Inoue M, Widermann B. [https://doi.org/10.1111/j.1469-0691.1997.tb00643.x Inducible β-lactamase-mediated resistance to third-generation cephalosporins]. ''Clin Microbio Infect''. 1997;3(1):S7-S20.
* Jones R, Baquero F, Privitera G, Inoue M, Widermann B. [https://doi.org/10.1111/j.1469-0691.1997.tb00643.x Inducible β-lactamase-mediated resistance to third-generation cephalosporins]. ''Clin Microbio Infect''. 1997;3(1):S7-S20.

Latest revision as of 14:44, 25 October 2024

Background

  • Gram-negative bacteria with inducible or derepressable beta-lactamases, primarily AmpC β-lactamase

Organisms

Management

Further Reading